Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Ziopharm reports 4Q loss on costs

March 1, 2011 2:45 am | by The Associated Press | News | Comments

Biotechnology company Ziopharm Oncology Inc. on Tuesday reported a fourth-quarter loss on higher operating costs and a decline in the value of its warrants.The company reported a net loss of $11.9 million, or 25 cents per share, in the three months ended Dec 31. That compares with profit of...

WuXi PharmaTech Schedules Fourth-Quarter 2010 Earnings Release

March 1, 2011 2:37 am | by Bio-Medicine.Org | News | Comments

SHANGHAI, March 1, 2011 / PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the...

TOPICS:

Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis

March 1, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., March 1, 2011 /- Pervasis Therapeutics, Inc. announced today that the European Commission (EC) has granted Orphan Drug Designation for Vascugel® for the prevention of hemodialysis vascular access failure in patients with end stage renal disease (ESRD). The...

TOPICS:
Advertisement

Dehaier Medical Announces March Investor Presentations

March 1, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

BEIJING, March 1, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that management...

TOPICS:

WARFARIN Study Launched to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin

March 1, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., March 1, 2011 /- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study ( W arfarin A dverse Event R eduction f or A dults R eceiving Genetic Testing at Therapy In itiation) was initiated in major hospital systems nationwide to assess the utility of...

TOPICS:

March 2011 Digital Edition

March 1, 2011 12:00 am | Digital Editions | Comments

Inside: Read about a new testing system for human interface adhesives in “Next Generation Human Interface Adhesive Sections,” from Avery Dennison Medical Solutions. Shared are professionals’ opinions on replacing pharma, testing and FDA compliance, and telemonitoring. Additionally, read about ultra short pulse laser processing, green laser marking, electromechanical and mechanical devices, and molding.

TOPICS:

Microelectronics Innovation Collaborative Centre licenses Alchimer?s wet deposition products for MEMS 3D research

February 28, 2011 7:38 pm | by I-Micronews | News | Comments

Canadian Research-and-Development Consortium Will Use Wet Deposition Technology to Advance MEMS Production.

Release of IGBT module for advanced neutral point clamped (NPC) circuits series

February 28, 2011 7:38 pm | by I-Micronews | News | Comments

World?s first module with a 3-level platform in a single package

Advertisement

Cree launches industry?s first surface-mount 1200-V silicon carbide Schottky diode

February 28, 2011 7:38 pm | by I-Micronews | News | Comments

Surface-mount TO-252 D-Pak device can enable smaller, lower-cost, and more-efficient solar-power micro-inverters.

Better Bioimaging with a Liquid Lens

February 28, 2011 7:37 pm | by Massachusetts Institute of Technology | News | Comments

New device produces high-resolution 3-D images beneath the skin.

A One-Hour Cancer Detector

February 28, 2011 7:37 pm | by Massachusetts Institute of Technology | News | Comments

A device that plugs into a smart phone lets clinicians diagnose cancer from the bedside.

Effects of depression on quality of life improvement after endoscopic sinus surgery

February 28, 2011 7:34 pm | by EurekAlert | News | Comments

(American Academy of Otolaryngology - Head and Neck Surgery) Depression is a common problem in patients with chronic rhinosinusitis and negatively impacts patients' symptom burden, ability to function, and quality of life, according to new research published in the March 2011 issue of...

TOPICS:

Berkeley Lab's Advanced Light Source Finds Big Surprise in Paleozoic Scorpion Fossil

February 28, 2011 4:37 pm | by Lawrence Berkeley National Laboratory | News | Comments

It's not quite Jurassic Park, but who wants Paleozoic scorpions scurrying around anyway? Scientists used a powerful microscope at Berkeley Lab's Advanced Light Source to detect remnants of protein and chitin in the exoskeleton of a 417-million-year-old fossil of an extinct mega-scorpion,...

TOPICS:

Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities

February 28, 2011 4:34 pm | by EurekAlert | News | Comments

(American Society of Hematology) Results from a study published in Blood, the journal of the American Society of Hematology, reveal a close relationship between pulmonary arterial hypertension -- exceedingly high blood pressure in the arteries carrying blood from the heart to the lungs --...

TOPICS:

Feds awards $215 million pacts for flu vaccines

February 28, 2011 3:46 pm | by The Associated Press | News | Comments

Drug makers Novavax Inc. and VaxInnate Inc. have won contracts worth a combined $215 million to develop flu vaccines for the U.S. Department of Health and Human Services.The news sent shares of Novavax up 68 cents, or nearly 26 percent, to $3.19 in after-hours trading.The goal of the contracts...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading